logo

End-to-End Vaccine Manufacturing Facility in Nigeria

One of 10,000+ projects Taiyo tracks in Nigeria.

Source: The Whistler Newspaper

Project
Planned

Establishment of an indigenous, end-to-end vaccine manufacturing company in Nigeria that conducts research and development, produces active pharmaceutical ingredients, and carries out fill-and-finish operations for vaccines including Lassa fever, HIV, Ebola, and others. The facility aims to enhance national health security, create high-technology jobs, and reduce vaccine import dependency.

Status
Prospective
Sector
Manufacturing (Industrial), Government
Location
Abuja, Nigeria
Updated
22 Jul 2026
Source
The Whistler Newspaper

ConstructChat

Ask ConstructChat about End-to-End Vaccine Manufacturing Facility in Nigeria

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

5 Q
The project “End-to-End Vaccine Manufacturing Facility in Nigeria” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Abuja, Nigeria. Taiyo aggregates data on it from The Whistler Newspaper.

Participants

Sponsoring Agency

Status

Original status

planned

Taiyo status

Prospective

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Establishment of an indigenous, end-to-end vaccine manufacturing company in Nigeria that conducts research and development, produces active pharmaceutical ingredients, and carries out fill-and-finish operations for vaccines including Lassa fever, HIV, Ebola, and others. The facility aims to enhance national health security, create high-technology jobs, and reduce vaccine import dependency.

Original sector

Healthcare

Budget

Location

Country

Nigeria

City

Abuja

Source

Source

The Whistler Newspaper

URL

More Details

Record type

Project

Sector

Manufacturing (Industrial), Government

Article published date

2025-12-21

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project